AIM
AMRX icon

Alambic Investment Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Alambic Investment Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-19,493
Closed -$93K – 77
2020
Q2 		$93K Sell
19,493
-13,300
-41% -$54.8K 0.23% 135
2020
Q1 		$114K Sell
32,793
-146,107
-82% -$619K 0.28% 121
2019
Q4 		$862K Buy
178,900
+140,700
+368% +$489K 0.72% 30
2019
Q3 		$111K Buy
+38,200
New +$133K 0.08% 258

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Alambic Investment Management's AMRX Position: Q3 2020 in Review

Alambic Investment Management sold out of Amneal Pharmaceuticals (AMRX) in Q3 2020, closing a stake of 19,493 shares — an estimated $93K sold.

Alambic Investment Management first reported a position in AMRX in Q3 2019 and held it in 4 quarters. The position peaked at $862K in Q4 2019. 140 funds tracked by Wall St. Rank hold AMRX as of Q3 2020.

  • Alambic Investment Management reported no remaining Amneal Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Alambic Investment Management sold 19,493 Amneal Pharmaceuticals shares in Q3 2020, an estimated $93K.
  • Alambic Investment Management first reported a position in Amneal Pharmaceuticals in Q3 2019 and held it in 4 quarters.
  • Alambic Investment Management's Amneal Pharmaceuticals position peaked at $862K in Q4 2019.
  • 140 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2020.

Based on Alambic Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.